The European Commission has signed a 63 million euro contract with US pharmaceutical Gilead to ensure the supply of the drug ‘Veklury,’ its trade name for Remdesivir, to some 30,000 patients with severe symptoms of Covid-19 during the summer months.Late last month, the US Department of Health and Human Services struck a deal to buy nearly all of Gilead’s projected production until the end of September.